GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Profiling chemical tumor microenvironment: Application for diagnostics & therapy

$327,013
Valery V Khramtsov · West Virginia University · R01 · FY2024 · CA

Chemokines, TRP Channels and Cancer Pain

$327,010
Durga Prasanna Mohapatra · University Of Iowa · R01 · FY2014 · NS

Single cell investigation of co-evolution in cancer cells and host cell immune microenvironment

$327,006
Shuqiang Li · Dana-Farber Cancer Inst · R50 · FY2025 · CA

Collaborative Research: Mimicking Stress-Mediated Invasive Solid Tumor Using Bioprinted Microtissue and Acoustofluidics

$327,000
Amir K Miri · New Jersey Institute Of Technology · · FY2023 · ENG

Hypoxia, Genetic Instability and DNA Mismatch Repair

$327,000
Yale University · R01 · FY2005 · ES

Hypoxia, Genetic Instability and DNA Mismatch Repair

$327,000
Yale University · R01 · FY2004 · ES

Cannabinoid CB2 Agonists for Treatment of Breast Cancer Induced Bone Pain

$326,992
Todd W Vanderah · University Of Arizona · R01 · FY2019 · CA

CSF1 signaling in gliomagenesis

$326,983
Lara S Collier · University Of Wisconsin-Madison · R01 · FY2017 · NS

AstroPath Integration Resource Core

$326,962
Alexander S Szalay · Johns Hopkins University · U54 · FY2022 · CA

MR Dynamic Imaging and Spectroscopy in Head & Neck Cancers

$326,955
Amita Dave · Sloan-Kettering Inst Can Research · R01 · FY2006 · CA

The identification of human hepatocellular carcinoma metastasis genes

$326,950
Xin Wang · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Functional Determinants of Metastatic Dormancy

$326,938
Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · CA

Informatics for Integrative Brain Tumor Whole Slide Analysis

$326,868
Joel H Saltz · State University New York Stony Brook · R01 · FY2013 · LM

Treating recurrent HNSCC with radiation and dual TGF-Beta/PD-L1.

$326,821
Xiao-Jing Wang · University Of Colorado Denver · P50 · FY2024 · CA

Manipulation of Tumor Specific Immunity

$326,781
Hans Schreiber · University Of Chicago · R01 · FY2022 · CA

Combining targeted radionuclide therapy with a localized in situ vaccine to overcome immune suppression in the tumor microenvironment and augment T cell responses

$326,693
Paul M Sondel · University Of Wisconsin-Madison · P01 · FY2020 · CA

T cell therapy targeting multiple tumor antigens in lymphoma

$326,678
Ann M. Leen · Baylor College Of Medicine · P50 · FY2019 · CA

Bioinformatics Tools for Genomic Analysis of Tumor and Stromal Pathways in Cancer

$326,559
Giovanni Parmigiani · Dana-Farber Cancer Inst · R01 · FY2015 · CA

Molecular basis for HIV therapy-linked osteopenia

$326,555
Jeffrey C Laurence · Weill Medical Coll Of Cornell Univ · R01 · FY2007 · DK

Project 3: Modulating Androgen Receptor Signaling to Enhance the Efficacy of CAR T Cell Therapy for Advanced Prostate Cancer

$326,549
John Kyung Lee · Fred Hutchinson Cancer Center · P50 · FY2023 · CA

Kallikrein-Targeted Alpha-Particle Therapy of Late-Stage Prostate Cancer

$326,508
Daniel Lyndon Jaffe Thorek · Washington University · R01 · FY2019 · CA

Re-activating Memory T Cells in the Microenvironment of Human Tumors

$326,466
Richard B Bankert · State University Of New York At Buffalo · R01 · FY2017 · CA

Role of hematopoietic microenvironment in plexiform neurofibroma progression

$326,453
David W. Clapp · Ut Southwestern Medical Center · P50 · FY2010 · NS

Drug Resistance in Multiple Myeloma

$326,408
H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2005 · CA

Drug Resistance in Multiple Myeloma

$326,408
H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2004 · CA